Yahoo Web Search

Search results

1. • 

     Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why

     Zacks via Yahoo Finance· 4 months ago

     Shares of Instil Bio, Inc. TIL have rallied 22.2% in the past week against the industry’s decrease...

2. • 

     Why Iovance Stock Is Down 18% Today

     Motley Fool via Yahoo Finance· 2 weeks ago

     Iovance Biotherapeutics (NASDAQ: IOVA) shares are down to the tune of 18% today following Thursday evening's release of its first-quarter numbers. The...

3. • 

     Why Shares of Iovance Biotherapeutics Dropped Thursday

     Motley Fool· 8 months ago

     Shares of Iovance Biotherapeutics (NASDAQ: IOVA) fell more than 13% on Thursday. The biotech...

4. • 

     Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

     Simply Wall St. via Yahoo Finance· 1 month ago

     Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is possibly approaching a major achievement in its...

5. • 

     New cell-based therapy for melanoma more effective than existing treatment, trial finds

     NBC News via Yahoo News· 2 years ago

     European researchers announced Saturday that a new treatment for advanced melanoma was more...

6. • 

     2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street

     Motley Fool via Yahoo Finance· 2 months ago

     Whether you realize it or not, for over a year now, picking growth stocks that perform well has been...

7. • 

     Iovance, with approval of ‘TIL’ cell therapy, readies for complex launch

     BioPharma Dive via Yahoo Finance· 3 months ago

     The biotech set a price of roughly $515,000 per patient for its therapy Amtagvi, the first to be...

8. • 

     Why Iovance Biotherapeutics Stock Is Dropping Tuesday

     Motley Fool· 10 months ago

     Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were down more than 8% as of 10:45 a.m. ET on...

9. • 

     MedWatch Digest: A warning for patients with diabetes who rely on insulin — and more

     WGN Chicago via Yahoo News· 2 months ago

     For Monday, March 25, WGN’s Patrick Elwood and Jenna Barnes have the latest on new medical...

10. • 

      Nektar (NKTR), Cellular Biomedicine Join for Lung Cancer Studies

      Zacks via Yahoo Finance· 8 months ago

      Nektar NKTR announced a partnership with Cellular Biomedicine to develop its pipeline candidate,...